TU1.R3.1
Development of continuous hydrogenation for pharmaceutical intermediate from Laboratory to Pilot plant
Onkar Manjrekar, Greg Storer, Brian Kotecki, Jie Chen, Moiz Diwan, AbbVie, United States
Session:
TU1.R3: Biopharmaceutical Reaction Engineering I
Track:
Biopharmaceutical Reaction Engineering – All Modalities
Location:
Room 3
Presentation Time:
Tue, 18 Feb, 10:45 - 11:05 CT (UTC -6)
Presentation
Discussion
Resources
No resources available.
Session TU1.R3
TU1.R3.1: Development of continuous hydrogenation for pharmaceutical intermediate from Laboratory to Pilot plant
Onkar Manjrekar, Greg Storer, Brian Kotecki, Jie Chen, Moiz Diwan, AbbVie, United States
TU1.R3.2: DEVELOPMENT OF PHARMACEUTICALLY-RELEVANT PHOSPHOLIGANDS FROM LAB TO PLANT VIA MULTI-STAGE FLOW CHEMISTRY
Eric Sacia, Anna Bay, Shashank Shekhar, Kaid Harper, Justin Simanis, Simona Slater, Onkar Manjrekar, Christopher Vitale, AbbVie, United States
TU1.R3.3: DEVELOPMENT AND DEMONSTRATION OF AN ULTRA-HIGH TEMPERATURE CONTINUOUS RACEMIZATION PROCESS FOR RECYCLE OF UNDESIRED ATROPISOMER WASTE STREAM
Kiersten Campbell, Eric Fang, David Ford, Kevin Nagy, Jillian Sheeran, Snapdragon Chemistry, Inc., A Cambrex Company, United States
Contacts